Madison Physician Agrees to Pay $110,000 to Resolve Allegations of Controlled Substance Prescribing Violations
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Madison Physician Agrees to Pay $110,000 to Resolve Allegations of Controlled Substance Prescribing Violations

Madison Physician Agrees to Pay $110,000 to Resolve Allegations of Controlled Substance Prescribing Violations

Marzo 12, 2021
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Luis Agostini
Phone Number: 312-353-7875

MADISON, Wis. – Special Agent in Charge Robert J. Bell, Drug Enforcement Administration (DEA) – Chicago Division and Acting United States Attorney Timothy M. O’Shea announced that David E. Eckerle, M.D., a Madison, Wisconsin physician, entered into a settlement agreement to pay $110,000 to resolve civil allegations that he violated the Controlled Substances Act (CSA) related to the manner in which he was prescribing opioids and other controlled substances.  

According to the settlement agreement, the government alleged that between May 2016 and January 2020, Dr. Eckerle wrote prescriptions for opioids and other controlled substances that had no legitimate medical purpose and were not issued in the usual course of professional practice.   

In enacting the CSA, Congress recognized the importance of preventing the diversion of drugs from legitimate to illegitimate uses. The CSA, in relevant part, deters the illegal distribution, possession, dispensing, and improper use of controlled substances, all of which have contributed significantly to the opioid epidemic over the past two decades. The CSA therefore regulates entities and practitioners that dispense controlled substances by establishing controls over all stages of the chain of distribution of controlled substances in the United States. 

“The opioid epidemic has caused great harm and deep sadness to individuals, families, and communities here in Wisconsin. In cases unrelated to this matter, this office has seen opiate addictions that begin with a doctor over-prescribing opiate pain pills and that end with the former patient overdosing on heroin or going to prison for drug-related crimes. Wisconsin physicians who increase risks of opiate addiction by irresponsibly prescribing opioids will be held accountable,” said Acting United States Attorney O’Shea. “This office will investigate inappropriate opioid prescribing and use all available tools to combat the opioid epidemic and protect our local communities.” 

“The harm caused by improperly prescribed narcotics is a serious threat to the health of our citizens,” said DEA Wisconsin Assistant Special Agent in Charge John McGarry. “This investigation is indicative of DEA’s commitment to improve public safety by ensuring physicians issue prescriptions for legitimate medical purposes within the boundaries of federal law.

Assistant U.S. Attorney Theresa Anzivino represented the government in this matter, and the DEA Madison Resident Office conducted the investigation. The settlement agreement states CSA allegations only; Dr. Eckerle denies the allegations and there has been no determination of liability. 

Wisconsin residents with unused prescriptions—especially opiates—in their homes can use this link to learn where drugs can be safely disposed.  https://doseofrealitywi.gov/drug-takeback/find-a-take-back-location/.   

 

# # # #

 

Download Press Release
###
Opioids Heroin
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Shane Catone Special Agent in Charge - Chicago
@DEAChicagoDiv
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster